Form 4 for VKTX Viking Therapeutics, Inc.
Accepted 2023-01-04 00:00:00 ET · period of report 2022-12-30 · accession 0001209191-23-001340 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-01-04 | 2022-12-30+ | VKTX | Lian Brian | Pres, CEO, Dir | A - Grant | $0.00 | +388.3K | 2.37M | +20% | $0 |
| DM | 2023-01-04 | 2022-12-30+ | VKTX | Lian Brian | Pres, CEO, Dir | F - Tax | $8.86 | -163.0K | 2.27M | -7% | -$1.44M |
| D | 2023-01-04 | 2023-01-03 | VKTX | Lian Brian | Pres, CEO, Dir | A - Grant | $0.00 | +600.0K | 600.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.00001 per share | 2022-12-30 | A | A | 121,667 | $0.00 | 2,169,294 | D | — | — | (F1) The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2019, 66.67% of which vested on December 30, 2022 upon the achievement of two non-financial performance goals and a performance restricted stock unit award that was granted on January 4, 2021, 33.33% of which vested on December 30, 2022 upon the achievement of a non-financial performance goal. (F2) Includes 4,545 shares acquired on May 20, 2022 and 6,396 shares acquired on November 18, 2022 pursuant to the Issuer's 2014 Employee Stock Purchase Plan. |
| 2 | Common | Common Stock, par value $0.00001 per share | 2022-12-30 | F | D | 66,127 | $9.40 | 2,103,167 | D | — | — | (F3) These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to certain performance restricted stock units. |
| 3 | Common | Common Stock, par value $0.00001 per share | 2023-01-03 | A | A | 266,667 | $0.00 | 2,369,834 | D | — | — | (F4) Represents a restricted stock unit award ("RSU") of common stock under the Issuer's 2014 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award. |
| 4 | Common | Common Stock, par value $0.00001 per share | 2023-01-03 | F | D | 68,252 | $8.52 | 2,301,582 | D | — | — | (F5) These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units. |
| 5 | Common | Common Stock, par value $0.00001 per share | 2023-01-04 | F | D | 28,619 | $8.42 | 2,272,963 | D | — | — | (F5) These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units. |
| 6 | Derivative | Stock Option (Right to Buy) | 2023-01-03 | A | A | 600,000 | $0.00 | 600,000 | D | $8.52 · 2024-01-03 to 2033-01-03 | 600,000 Common Stock | (F6) 25% of the shares subject to the option will vest on each anniversary of the grant date. |